Ditchcarbon
  • Contact
  1. Organizations
  2. Aquestive Therapeutics, Inc.
Public Profile
Pharmaceutical Preparation Manufacturing
US
updated a month ago

Aquestive Therapeutics, Inc. Sustainability Profile

Company website

Aquestive Therapeutics, Inc., a pioneering biopharmaceutical company headquartered in the United States, focuses on developing innovative therapies for patients with unmet medical needs. Founded in 2006, the company has made significant strides in the pharmaceutical industry, particularly in the areas of drug delivery and formulation technologies. Specialising in the development of oral films and other unique delivery systems, Aquestive's core products, such as the Suboxone Film, stand out for their ability to enhance patient compliance and improve therapeutic outcomes. With a commitment to addressing complex medical challenges, the company has established a strong market position, recognised for its advancements in the treatment of opioid dependence and other conditions. Through its dedication to innovation, Aquestive Therapeutics continues to shape the future of patient care.

DitchCarbon Score

How does Aquestive Therapeutics, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

23

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

30

Industry Benchmark

Aquestive Therapeutics, Inc.'s score of 23 is lower than 69% of the industry. This can give you a sense of how well the company is doing compared to its peers.

31%

Let us know if this data was useful to you

Aquestive Therapeutics, Inc.'s reported carbon emissions

Aquestive Therapeutics, Inc., headquartered in the US, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Furthermore, the company has not established any documented reduction targets or commitments to climate initiatives, such as those outlined by the Science Based Targets initiative (SBTi) or other industry standards. As a result, there are no significant achievements or targets to highlight regarding emissions reduction. The lack of emissions data and climate commitments suggests that Aquestive Therapeutics may still be in the early stages of developing a comprehensive sustainability strategy. In the context of the pharmaceutical industry, where climate action is increasingly critical, it will be essential for the company to consider establishing measurable targets and initiatives to address its environmental impact in the future.

How Carbon Intensive is Aquestive Therapeutics, Inc.'s Industry?

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Aquestive Therapeutics, Inc.'s primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

How Carbon Intensive is Aquestive Therapeutics, Inc.'s Location?

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Aquestive Therapeutics, Inc. is in US, which has a low grid carbon intensity relative to other regions.

Aquestive Therapeutics, Inc.'s Climate Goals (2030 & 2050)

Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.

Aquestive Therapeutics, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Compare Aquestive Therapeutics, Inc.'s Emissions with Industry Peers

Vertex Pharmaceuticals

US
•
Pharmaceutical Preparation Manufacturing
Updated 9 days ago

Indivior

US
•
Pharmaceutical Preparation Manufacturing
Updated 9 days ago

Akorn

US
•
Pharmaceutical Preparation Manufacturing
Updated 14 days ago

Pfizer

US
•
Pharmaceutical Preparation Manufacturing
Updated about 4 hours ago

Cumberland Pharmaceuticals Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated 2 days ago

Johnson And Johnson

US
•
Pharmaceutical Preparation Manufacturing
Updated 1 day ago

Let us know if this data was useful to you

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v251030.3
[email protected]+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
UL Solutions verification badge
CDP logo
Gartner Cool Vendor 2025 badge
ProductPortalScope 3 Tool FunctionalityDataIntegrationsPricing
CustomersHaleonGrant ThorntonHikmaRead all stories
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesCalculation MethodologyDocumentationBlogFAQOrganizationsIndustriesSBTI APITrust CentreChangelog
AboutTeamCareersLicense AgreementPrivacy